← All trials
NCT05751044
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2023
- Primary completion
- Oct 1, 2030
- Completion date
- Oct 1, 2030
- First posted
- Mar 2, 2023
- Last posted
- Apr 10, 2023
- Enrollment
- 26
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Princess Maxima Center for Pediatric OncologyLead sponsor
- Utrecht UniversityStudy chair
- Humboldt UniversityOverall official - principal investigator
- Innovative Therapies For Children with Cancer ConsortiumCollaborator
- Fight Kids CancerCollaborator
- Utrecht UniversityOfficial
- Humboldt UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.